Target Enrichment and Targeted Panels

One of the biggest challenges of NGS is target selection. By leveraging our expertise in the ever-increasingly complex medical knowledge base, we ensure your tests target all the right variants, and can provide you with the answers you need. ...

Read more

One of the biggest challenges of NGS is target selection. By leveraging our expertise in the ever-increasingly complex medical knowledge base, we ensure your tests target all the right variants, and can provide you with the answers you need.

The GeneRead QIAact Targeted Panels are purpose-built for clinical research labs, designed to identify new variants of potential interest in meaningful pathway genes. Content is carefully selected, targeting only genes and variants that are important to specific disease areas.

The QIAGEN Knowledge Base was built to help you interpret variants in their clinical context, but is also used to direct the selection process for the Target Enrichment panel design by focusing on significant genes and genomic regions for translational and clinical research. The QIAGEN curation process is an industry-leading, best-in-class pipeline with over 15 years of refinement. Having been started as a comprehensive biological knowledge base, it has now been expanded to include clinically relevant findings from drug labels, practice guidelines, clinical trials, primary literature and curated clinical cases. The same content is available in QIAGEN Clinical Insight, which provides a solution for variant interpretation and reporting.